Literature DB >> 3022718

Modulation of calcineurin phosphotyrosyl protein phosphatase activity by calmodulin and protease treatment.

R L Kincaid, T M Martensen, M Vaughan.   

Abstract

Calcineurin (CN) dephosphorylated [32P] phosphotyrosyl glutamine synthetase, a model phosphoprotein substrate containing approximately 1 mol of phosphotyrosine per mol subunit. Phosphatase activity with and without calmodulin (CaM) was greatly stimulated by Mn2+; with Ca2+, even in the presence of CaM, activity was very low. CaM-stimulated phosphatase activity exhibited deactivation with time; initial rates declined markedly after 2-3 min. The Michaelis constant for substrate (3 microM) was identical whether 2 or 12 min assays (with CaM) were used suggesting that the decreased rate of hydrolysis did not result from a decrease in affinity for the phosphoprotein substrate. Limited proteolysis of CN by chymotrypsin increased phosphatase activity 2-3 times that of CaM-supported activity; however, addition of CaM to assays with protease-activated CN reduced activity to that observed for non-proteolyzed enzyme. These data suggest that, in addition to stimulation, CaM can inhibit certain activated conformations of the phosphatase.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3022718     DOI: 10.1016/0006-291x(86)91093-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  Phosphotyrosyl protein phosphatases.

Authors:  K H Lau; J R Farley; D J Baylink
Journal:  Biochem J       Date:  1989-01-01       Impact factor: 3.857

2.  Characterization of a cDNA clone encoding the calmodulin-binding domain of mouse brain calcineurin.

Authors:  R L Kincaid; M S Nightingale; B M Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

3.  Transgenic overexpression of active calcineurin in beta-cells results in decreased beta-cell mass and hyperglycemia.

Authors:  Ernesto Bernal-Mizrachi; Corentin Cras-Méneur; Bo Ra Ye; James D Johnson; M Alan Permutt
Journal:  PLoS One       Date:  2010-08-03       Impact factor: 3.240

4.  Prostaglandin E2 and other cyclic AMP elevating agents inhibit interleukin 2 gene transcription by counteracting calcineurin-dependent pathways.

Authors:  F Paliogianni; R L Kincaid; D T Boumpas
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.